You are here: Industry Insights > Generic

News List

Generic = Branded Drug, What are the Facts? Krebs Qin
July 03, 2024
It is no secret that the U.S. military does not trust the quality of generic drugs, and their disagreements and disagreements with the FDA over the quality control of generic drugs have long been made public.
IGBA launches whitepaper on global generic and biosimilar medicines industry expresspharma
July 08, 2021
It covers opportunities, challenges and disruptions for the industry, vision for 2030 as well as actions needed to achieve this vision.
Chinese patent reforms to bolster pharma innovation europeanpharmaceuticalreview
June 18, 2021
Market research suggests the new drug patent reforms in China, in addition to other regulatory changes, will incentivise innovative pharma research.
Generic Pharmasec signs distribution and marketing pact with Abbott Point of Care expresspharma
June 01, 2021
The company has entered into an agreement with Abbott Point of Care (APOC), the medical and diagnostics devices division of Abbott, for the distribution, marketing and promotion of the entire range of products by APOC in the entire country of India.
The Biden effect on India Pharma Inc expresspharma
December 02, 2020
Stakeholders share their views and insights on the impact of a change of guard at the White House and outline India Pharma Inc's expectations from the Biden administration.
Lannett Launches Authorized Generic of Tirosint® (Levothyroxine Sodium Capsules) prnewswire
November 05, 2020
Lannett Company, Inc. announced that it has commenced the launch of the authorized generic of Tirosint® (Levothyroxine Sodium Capsules USP).
Dr Reddy’s launches generic opioid antagonist injection in US expresspharma
March 23, 2020
The product is a generic version of ADAPT Pharma Operations's Narcan injection.
Dr Reddy’s launches generic Ziprasidone Mesylate for injection in US expresspharma
March 20, 2020
Dr Reddy’s Laboratories said it has launched in the US generic Ziprasidone Mesylate for injection used for treatment of acute agitation in schizophrenic patients.
Mylan generic of lung cancer drug Alimta approved europeanpharmaceuticalreview
September 04, 2019
Mylan NV’s generic version Eli Lilly and Co’s lung cancer drug, Alimta, has been given tentative approval by the FDA.
FDA announces expansion of generic impurity investigation europeanpharmaceuticalreview
September 02, 2019
The examination of ARB drugs by the FDA will be extended to include other generics with similar manufacturing processes to identify impurities.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page